The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas
- 15 March 2022
- journal article
- research article
- Published by Springer Nature in Brain Tumor Pathology
- Vol. 39 (2) , 79-87
Abstract
The relevance of oligodendroglial histological features to patient prognoses is controversial. 93 LrGGs resected for about 2 decades were re-assessed based on WHO2007 with special interest to pure oligodendroglial diagnosis (oligodendroglioma or anaplastic oligodendroglioma) and presence of CFO features. Those histological features, patients OS, and tumor chromosomal/genetic characteristics were correlated each other in each of the 3 IDH-1p/19q-based molecular groups. There was significant association between 1p19q status with the oligodendroglial histological diagnosis as well as presence of CFO in the entire cohort. The oligodendroglial diagnosis was associated with longer OS in IDHmut/codel group; however, this association was not significant in the multivariate analyses. In IDHmut/noncodel and IDH-wildtype groups, the oligodendroglial diagnosis was not associated with patient OS. Presence of CFO was not associated with patient OS in any molecular groups. Gain of 8q was associated with the oligodendroglial diagnosis in IDHmut/noncodel group. Neither the oligodendroglial diagnosis nor CFO was predictive for the methylation status of the MGMT gene in any molecular groups. The oligodendroglial histological features are not independently predictive of either patient prognosis or chemotherapeutic response in LrGGs, leaving the possibility of marginal favorable association only in IDHmut/codel tumors.Keywords
This publication has 23 references indexed in Scilit:
- Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1CNS Oncology, 2015
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade GliomasNew England Journal of Medicine, 2015
- Mutational landscape and clonal architecture in grade II and III gliomasNature Genetics, 2015
- Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cellsActa Neuropathologica, 2013
- Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancersThe Journal of Pathology, 2011
- Single-Copy Gain of Chromosome 1q Is a Negative Prognostic Marker in Pediatric Nonependymal, Nonpilocytic GliomasNeurosurgery, 2011
- IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor GroupClinical Cancer Research, 2010
- Anaplastic Oligodendroglial Tumors: Refining the Correlation among Histopathology, 1p 19q Deletion and Clinical Outcome in Intergroup Radiation Therapy Oncology Group Trial 9402Brain Pathology, 2008
- The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsCancer, 2005
- Tissue Microdissection and Degenerate Oligonucleotide Primed-Polymerase Chain Reaction (DOP-PCR) Is an Effective Method to Analyze Genetic Aberrations in Invasive TumorsThe Journal of Molecular Diagnostics, 2001